Abbott Laboratories (ABT)

NYQ – Real Time Price. Currency in USD

94.12

+0.88 (0.94%)

At close: Jun 26, 2026, 4:03 PM EDT

93.90

-0.22 (-0.23%)

After-hours: Jun 26, 2026, 8:00 PM EDT

16.06.2026

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

ABT's CGM sales growth slows in Q1, but management sees a return to double-digit gains as Libre expands with new products and AI tools.

15.06.2026

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Wall Street rallied toward record highs Monday as President Donald Trump declared the Strait of Hormuz reopened and oil prices plunged, yet a cluster of the market's biggest names are still trading well below their pre-war levels.

12.06.2026

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott (ABT) closed the most recent trading day at $88.18, moving 1.64% from the previous trading session.

12.06.2026

Abbott declares 410th consecutive quarterly dividend

ABBOTT PARK, Ill., June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

12.06.2026

Abbott Laboratories Remains Structurally Undervalued

Abbott Laboratories is rated a strong buy due to structural undervaluation and resilient fundamentals despite recent negative price action. ABT trades at a 17.1% P/E and 35.1% sales multiple discount to peers, with DCF fair value estimates implying 21.8–39.4% upside. Growth is underpinned by the Exact Sciences acquisition, diagnostics megatrends, and global expansion in CGM, with FY26 guidance raised for both sales and EPS.

10.06.2026

Abbott (ABT) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Abbott (ABT) closed at $89.17, indicating a -2.28% shift from the previous trading day.

10.06.2026

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.

Videos

22.01.2026

Positive

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

22.01.2026

Neutral

Cramer's Mad Dash: Abbott Labs

Press releases

12.06.2026

Abbott declares 410th consecutive quarterly dividend

ABBOTT PARK, Ill., June 12, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

Abbott Laboratories (ABT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Abbott Laboratories (ABT)

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott declares 410th consecutive quarterly dividend

Abbott Laboratories Remains Structurally Undervalued

Abbott (ABT) Dips More Than Broader Market: What You Should Know

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Videos

Press releases

Abbott declares 410th consecutive quarterly dividend

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott declares 410th consecutive quarterly dividend

Abbott Laboratories Remains Structurally Undervalued

Abbott (ABT) Dips More Than Broader Market: What You Should Know

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Videos

Press releases

Abbott declares 410th consecutive quarterly dividend

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

Search stocks

Abbott Laboratories (ABT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Abbott Laboratories (ABT)

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott declares 410th consecutive quarterly dividend

Abbott Laboratories Remains Structurally Undervalued

Abbott (ABT) Dips More Than Broader Market: What You Should Know

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Videos

Press releases

Abbott declares 410th consecutive quarterly dividend

Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott declares 410th consecutive quarterly dividend

Abbott Laboratories Remains Structurally Undervalued

Abbott (ABT) Dips More Than Broader Market: What You Should Know

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Videos

Press releases

Abbott declares 410th consecutive quarterly dividend

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes